MedTrace Logo

"Efficacy Of 1.2% Rosuvastatin Gel In The Management Of Infrabony Defects"

NCT03677297 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2018-09-19

No results posted yet for this study

Summary

Study aims to evaluate clinical and radiographic effectiveness of 1.2% Rosuvastatin gel in the treatment of Infrabony defects in chronic periodontitis patients.

Conditions

  • Adult Periodontitis

Interventions

DRUG

Rosuvastatin

Test sites were treated with access flap surgery and 1.2% Rosuvastatin gel

Sponsors & Collaborators

  • Dr. D. Y. Patil Dental College & Hospital

    lead OTHER

Principal Investigators

  • Sukhada D Deo, BDS · Dr. D. Y. Patil Dental College & Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-28
Primary Completion
2017-08-01
Completion
2017-11-10

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03677297 on ClinicalTrials.gov